Boyanov, M. (2026) “Serum levels of Lipocalin-2/NGAL, Kidney Injury Molecule 1 (KIM-1), and Interleukin-18 are not related to risk predictions for cardiovascular and renal events in type 2 diabetes”, Acta Medica Bulgarica, 53(3), pp. 17–24. doi:10.2478/AMB-2026-0068.